Event-Driven Stocks

CEN BIOTECH INC

Healthcare · Pharmaceutical Preparations · Z4 · SEC filings ↗ · Compare ⊕

Signs● 2 good● 4 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY21FY20FY19FY18FY17FY16
Revenue$626,867$0——$0$0
Operating income−$19.0M−$2.5M−$2.6M−$4.4M−$11.6M−$6.6M
Net income−$18.9M$14.2M−$5.7M−$7.5M−$14.1M−$8.2M
Total assets$8.4M$6.3M$7.3M$7.3M$9.0M$8.4M
Total liabilities$10.1M$16.3M$32.8M$28.6M$28.0M$22.5M
Equity−$1.7M−$10.0M−$25.5M−$21.3M−$19.0M−$5.8M
EPS (diluted)$-0.45$0.45$-0.21———
Shares out.27.6M27.0M25.5M25.1M10.5M6.9M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2021
Operating margin
−3036.9%
Net margin
−3015.6%
Return on equity
1140.1%
Return on assets
−224.0%
Return on capital (ROCE)
—
Liabilities / assets
119.6%
Debt / equity
—
Book value / share
$-0.06
Revenue growth (YoY)
—
Net income growth (YoY)
−232.7%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2021
Altman Z″ (distress)
-40.38distress
Accruals / assets
−220.0%clean
Piotroski F-Score
4/8mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
25
/ 100
Profitability 25Growth 0Catalyst 33Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 3 severe● 4 warning● 2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)